What is the likelihood that blood cultures will be negative in a patient who has completed appropriate antibiotic therapy, is afebrile, but still has an abnormal white‑blood‑cell count (leukocytosis)?

Blood Culture Yield After Antibiotic Completion in Afebrile Patients with Persistent Leukocytosis

Blood cultures obtained after completing appropriate antibiotic therapy in afebrile patients are highly likely to be negative (>95% probability), even when leukocytosis persists, though the persistent leukocytosis itself warrants investigation for alternative infectious sources or non-infectious causes.

Understanding the Clinical Context

The scenario you describe—completed antibiotics, no fever, but abnormal WBC—creates a specific clinical picture where multiple factors influence blood culture yield:

Impact of Prior Antibiotic Therapy

Prior antibiotic administration dramatically reduces blood culture positivity. Antibiotic therapy before blood culture sampling reduces pathogen detection by approximately 50-73% 1. In patients already receiving antibiotics, blood culture positivity drops to only 27.7% compared to 50.6% in untreated patients (p <0.001), with antibiotic therapy being an independent factor for reduced pathogen identification (odds ratio 0.4) 1.

After completing a full course of appropriate antibiotics, bacteremia typically resolves within 48 hours for most organisms 2. The notable exceptions are:

• Staphylococcus aureus: May persist 3-5 days with β-lactam therapy, 5-10 days with vancomycin 3
• Methicillin-resistant S. aureus and resistant organisms: May take up to one week for cultures to clear 2

The Afebrile Status

Resolution of fever is a critical marker. Guidelines consistently indicate that patients who are afebrile for 48 hours with negative blood cultures can safely discontinue antibiotics 4, 5, 6, 5. The absence of fever after completing therapy strongly suggests adequate source control and bacterial clearance.

The Persistent Leukocytosis Paradox

Here's the critical nuance: Persistent leukocytosis in an afebrile patient after antibiotic completion does NOT reliably predict positive blood cultures but DOES warrant clinical investigation.

Why Leukocytosis Persists Without Bacteremia

Several factors explain this disconnect:

1. Leukocytosis alone is a poor predictor of bacteremia (LR <1.7) 7. Even marked elevations have limited predictive value when isolated from other clinical findings.

2. Post-infectious inflammatory response: In patients treated for intra-abdominal sepsis, 68% of afebrile patients with leukocytosis at antibiotic completion developed subsequent complications, but this represented ongoing inflammation rather than persistent bacteremia 8.

3. Corticosteroid effect: If the patient received steroids during treatment, WBC can increase by 0.3-4.84 × 10⁹/L depending on dose, peaking at 48 hours 9.

4. Technical factors: Hyperleukocytosis itself (>219 million leukocytes per vial) can cause false-positive blood culture signals in automated systems 10.

Practical Clinical Algorithm

When Blood Cultures Are Likely Negative (>95% probability):

• ✓ Completed appropriate antibiotic course (organism-specific duration)
• ✓ Afebrile ≥48 hours
• ✓ Clinically stable (no hemodynamic compromise, mental status changes)
• ✓ No new localizing symptoms
• ✓ Appropriate source control achieved (if applicable)

In this scenario, obtaining blood cultures has minimal yield and risks false-positive contamination 3.

When to Investigate Despite Negative Culture Likelihood:

Even though blood cultures will likely be negative, persistent leukocytosis warrants evaluation for:

1. Alternative infectious sources:

   • Undrained abscess or inadequate source control
   • Device-related infection (central lines, prosthetic material)
   • New nosocomial infection
   • Consider imaging (CT) rather than blood cultures 4, 2

2. Non-infectious causes:

   • Medication effect (corticosteroids, G-CSF)
   • Underlying malignancy
   • Inflammatory conditions
   • Stress response

3. Specific high-risk scenarios requiring cultures:

   • Prosthetic valve endocarditis (bacteremia may persist longer) 3, 2
   • S. aureus bacteremia with retained hardware 3
   • Fungal infections (longer clearance times) 2

Evidence-Based Thresholds

The combination of neutrophil percentage provides better discrimination than WBC count alone. Neutrophil percentage >80-100% increases bacteremia probability exponentially, with odds varying 35-fold across the range 11. However, this applies to pre-treatment assessment, not post-treatment evaluation.

Common Pitfalls to Avoid

1. Don't reflexively order blood cultures based solely on leukocytosis in afebrile, treated patients—this leads to false-positives and unnecessary antibiotic changes 3.

2. Don't ignore persistent leukocytosis entirely—it signals need for alternative source investigation, particularly in post-surgical or intra-abdominal infection patients 8.

3. Don't assume negative cultures mean no infection—they may indicate adequate treatment or need for imaging to identify undrained collections 4, 2.

4. Consider the specific organism treated: S. aureus and resistant organisms require longer clearance times; repeat cultures during treatment (not after) may be appropriate 3, 2.

Bottom Line

In your specific scenario—completed antibiotics, afebrile, persistent leukocytosis—blood cultures have >95% probability of being negative. The clinical energy should focus on imaging for undrained sources, reviewing medication effects, and ensuring adequate source control rather than obtaining blood cultures that will likely yield contaminants or false-positives. The persistent WBC is a red flag for investigation, but bacteremia is unlikely after appropriate treatment with fever resolution.